What to do When Decompressive Gastrostomies and Jejunostomies are not Options? A Scoping Review of Transesophageal Gastrostomy Tubes for Advanced Malignancies

• Published in: Annals of surgical oncology 2022, Vol.29 (1), p.262-271
• Main Authors: Zhu, Clara, Platoff, Rebecca, Ghobrial, Gaby, Saddemi, Jackson, Evangelisti, Taylor, Bucher, Emily, Saracco, Benjamin, Adams, Amanda, Kripalani, Simran, Atabek, Umur, Spitz, Francis R., Hong, Young K.
• Format: Article
• Language: English
• Subjects: Ascites; Balloon treatment; Decompression; Esophagus; Fluoroscopy; Gastric cancer; Gastrointestinal Oncology; Gastrostomy; Humans; Intubation, Gastrointestinal; Jejunostomy; Malignancy; Medicine; Medicine & Public Health; Oncology; Ostomy; Palliation; Patients; Peritoneal Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Surgery; Surgical Oncology
• ISSN: 1068-9265; 1534-4681
• DOI: 10.1245/s10434-021-10667-x

Background In advanced malignant bowel obstruction, decompressive gastrostomy tubes (GTs) may not be feasible due to ascites, peritoneal carcinomatosis, and altered gastric anatomy. Whereas nasogastric tubes (NGTs) allow temporary decompression, percutaneous transesophageal gastrostomy tubes (PTEGs) are an alternative method for long-term palliative decompression. This study performed a scoping review to determine outcomes with PTEG in advanced malignancies. Methods A systematic literature search was performed to include all studies that reported the clinical results of PTEGs for malignancy. No language, national, or publication status restrictions were used. Results The analysis included 14 relevant studies with a total of 340 patients. In 11 studies, standard PTEGs were inserted with a rupture-free balloon’s placement into the mouth or nose and esophageal puncture under fluoroscopy or ultrasound, followed by a guidewire into the stomach with placement of a single-lumen tube. Of 340 patients, 65 (19.1%) had minor complications, and 5 (2.1%) had significant complications, including bleeding and severe aspiration pneumonia. Of 171 patients, 169 with PTEGs (98.8%) reported relief of nasal discomfort from NGT and alleviation of obstructive symptoms. The one randomized controlled trial reported a significantly higher quality of life with PTEGs than with NGTs. Conclusions When decompression for advanced malignancy is technically not feasible with a gastrostomy tube, the PTEG is a viable, safe option for palliation. The PTEG is associated with lower significant complication rates than the gastrostomy tube and significantly higher patient-derived outcomes than the NGT.